NASDAQ: AMGN $146 Billion Large-Cap. Dow Industrial. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 61%. 1 Year Return 6%. 2021 YTD Return 11%. 2.8% dividend yield. 39 total dividend payments. Current Ex-Date in 21 days on Thu, Feb 11. Since Earnings 1%.
The 52 Week Low is $181.77 set on Thu, Mar 12, 2020.
The 52 Week High is $262.82 set on Mon, Jul 20, 2020.
The All-Time High is $262.82 set on Mon, Jul 20, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Amgen trades on the NASDAQ. AMGN's market cap is 145.9 Billion.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).
For Starters
Track your portfolio and more.
